Abacus Medicine Pharma Services (Farnborough, UK) is the new name for the healthcare and pharma services company previously known as Aposave.
The rebrand reflects the company’s plans to access to the US and Chinese markets.
Through its parallel distribution division, the organization has been providing access to pharmaceutical products and healthcare to Europeans for almost 20 years. In order to establish a global footprint, the group — which has three service lines: Clinical Trial Solutions (CTS), Commercial Partnerships (CP) and Unlicensed Medicines (ULM) — established a full healthcare and pharma services division with commercial headquarters in the UK in 2020. Today, it has companies in the US, UK, Denmark, Hong Kong and The Netherlands.
“We made an excellent start as Aposave and now as Abacus Medicine Pharma Services we plan to make significant strides forward,” commented managing director Simon Estcourt.